Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma

The development of curative glioblastoma treatments and tumour-specific contrast agents that can overcome the blood–brain barrier (BBB) and infiltrative tumour morphology remains a challenge. Apolipoprotein E3 (apoE3) is a high density lipoprotein apolipoprotein that chaperones the transcytosis of n...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajora, M. A., Ding, L., Valic, M., Jiang, W., Overchuk, M., Chen, J., Zheng, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal Society of Chemistry 2017
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609152/
https://www.ncbi.nlm.nih.gov/pubmed/28970916
http://dx.doi.org/10.1039/c7sc00732a

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609152/
https://www.ncbi.nlm.nih.gov/pubmed/28970916
http://dx.doi.org/10.1039/c7sc00732a

Ejemplares similares